Mullins Ewen, Bresson Jean-Louis, Dalmay Tamas, Dewhurst Ian Crawford, Epstein Michelle M, Firbank Leslie George, Guerche Philippe, Hejatko Jan, Moreno Francisco Javier, Naegeli Hanspeter, Nogué Fabien, Rostoks Nils, Sanchez Serrano Jose Juan, Savoini Giovanni, Veromann Eve, Veronesi Fabio, Casacuberta Josep, Afonso Ana, Lenzi Paolo, Papadopoulou Nikoletta, Raffaello Tommaso
EFSA J. 2024 Jul 11;22(7):e8894. doi: 10.2903/j.efsa.2024.8894. eCollection 2024 Jul.
EFSA was asked by the European Parliament to provide a scientific opinion on the analysis by the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) of Annex I of the European Commission proposal for a regulation 'on plants obtained by certain new genomic techniques (NGTs) and their food and feed, and amending regulation (EU) 2017/625'. The Panel on genetically modified organisms (GMO) assessed the opinion published by ANSES, which focuses on (i) the need to clarify the definitions and scope, (ii) the scientific basis for the equivalence criteria and (iii) the need to take potential risks from category 1 NGT plants into account. The EFSA GMO Panel considered the ANSES analysis and comments on various terms used in the criteria in Annex I of the European Commission proposal and discussed definitions based on previous EFSA GMO Panel opinions. The EFSA GMO Panel concluded that the available scientific literature shows that plants containing the types and numbers of genetic modifications used as criteria to identify category 1 NGT plants in the European Commission proposal do exist as the result of spontaneous mutations or random mutagenesis. Therefore, it is scientifically justified to consider category 1 NGT plants as equivalent to conventionally bred plants with respect to the similarity of genetic modifications and the similarity of potential risks. The EFSA GMO Panel did not identify any additional hazards and risks associated with the use of NGTs compared to conventional breeding techniques in its previous Opinions.
应欧洲议会要求,欧洲食品安全局(EFSA)就法国食品、环境与职业健康安全局(ANSES)对欧盟委员会一项法规提案附件一的分析提供科学意见,该法规提案是“关于通过某些新基因组技术(NGTs)获得的植物及其食品和饲料,并修订(EU)2017/625号法规”。转基因生物(GMO)小组评估了ANSES发表的意见,该意见侧重于(i)明确定义和范围的必要性,(ii)等效标准的科学依据,以及(iii)考虑1类NGT植物潜在风险的必要性。EFSA转基因生物小组审议了ANSES对欧盟委员会提案附件一中标准所使用的各种术语的分析和评论,并根据EFSA转基因生物小组先前的意见讨论了定义。EFSA转基因生物小组得出结论,现有科学文献表明,欧盟委员会提案中用作识别1类NGT植物标准的基因改造类型和数量的植物确实因自发突变或随机诱变而存在。因此,就基因改造的相似性和潜在风险的相似性而言,将1类NGT植物视为等同于传统培育植物在科学上是合理的。EFSA转基因生物小组在其先前的意见中未发现与使用NGT相比传统育种技术存在任何额外的危害和风险。